Clinical Trial Update: Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nonmyeloablative peripheral blood stem cell transplant with high-dose posttransplant cyclophosphamide in hematopoietic malignancies;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Malignancies

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• peripheral blood stem cell transplant

Snippet

Sponsor: NYU Langone Health | Conditions: Hematopoietic Malignancies | Phase 2 | Status: TERMINATED | Results posted: 2020-03-27